| Product | Description |
| Australia | Committed to the development and production of high quality aquatic vaccines for cold and warm water species in Australia. |
| Singapore | Was built from scratch and started to operate in January 2000. The centre's main goal is to perform R&D to produce high quality Aquatic Animal Health products and application strategies for the Asia-Pacific region. |
| United States | In the year 1999 a decision was made to enter the Aquatic Animal Health market in the USA following the lead of Intervet International. The first product licensed was CHORULON® (hCG). The second product licensed was a live attenuated vaccine for the prevention of Enteric Septicemia of Catfish (ESC) caused by Edwardsiella ictaluri. |
